Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProBion Active is a medical-grade probiotic dietary supplement developed and produced by Wasa Medicals AB in Sweden. It is specifically formulated for individuals with rapid, loose, or unrest digestion, as well as for travelers. Each oral tablet contains 2 billion CFU (colony-forming units) of live bacterial strains, including multiple strains of Lactobacillus and Bifidobacterium. The product utilizes a proprietary 'ProBion Matrix' technology, a controlled-release dry tablet system that ensures the delivery of viable probiotic bacteria to the gastrointestinal tract over a 180-minute period. The formulation also includes prebiotic inulin to support the growth of beneficial gut flora and xanthan to protect the bacteria during passage through the digestive system. It is free from GMOs, dairy, soy, wheat, and gluten, making it suitable for vegans and all age groups.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ProBion Active.